Nathalie Conway-James

Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands.

Michael Koblish, R. Dolle, Christopher T Saeui, 2008, Bioorganic & medicinal chemistry letters.

Novel malonamide derivatives as potent κ opioid receptor agonists

T. Graczyk, Michael Koblish, R. Dolle, 2007 .

Novel phenylamino acetamide derivatives as potent and selective κ opioid receptor agonists

Michael Koblish, R. Dolle, J. Cassel, 2006 .

Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonists.

Michael Koblish, R. Dolle, J. Cassel, 2006, Bioorganic & medicinal chemistry letters.

Novel trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines as mu opioid receptor antagonists with improved opioid receptor selectivity profiles.

R. Dolle, J. Cassel, B. Le Bourdonnec, 2008, Bioorganic & medicinal chemistry letters.

Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands.

Michael Koblish, R. Dolle, Christopher T Saeui, 2008, Bioorganic & medicinal chemistry letters.

Potent and highly selective kappa opioid receptor agonists incorporating chroman- and 2,3-dihydrobenzofuran-based constraints.

T. Graczyk, Michael Koblish, R. Dolle, 2005, Bioorganic & medicinal chemistry letters.